- Home
- EXEL vs ENTG Comparison
EXEL vs ENTG Comparison
Compare EXEL & ENTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- ENTG
- Stock Information
- Founded
- EXEL 1994
- ENTG 1966
- Country
- EXEL United States
- ENTG United States
- Employees
- EXEL N/A
- ENTG N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- ENTG Plastic Products
- Sector
- EXEL Health Care
- ENTG Industrials
- Exchange
- EXEL Nasdaq
- ENTG Nasdaq
- Market Cap
- EXEL 12.0B
- ENTG 12.2B
- IPO Year
- EXEL 2000
- ENTG 2000
- Fundamental
- Price
- EXEL $44.86
- ENTG $87.58
- Analyst Decision
- EXEL Buy
- ENTG Strong Buy
- Analyst Count
- EXEL 18
- ENTG 10
- Target Price
- EXEL $43.65
- ENTG $110.40
- AVG Volume (30 Days)
- EXEL 3.7M
- ENTG 3.0M
- Earning Date
- EXEL 08-05-2025
- ENTG 07-30-2025
- Dividend Yield
- EXEL N/A
- ENTG 0.45%
- EPS Growth
- EXEL 237.58
- ENTG N/A
- EPS
- EXEL 2.20
- ENTG 2.04
- Revenue
- EXEL $2,298,922,000.00
- ENTG $3,243,408,000.00
- Revenue This Year
- EXEL $9.37
- ENTG $0.36
- Revenue Next Year
- EXEL $11.05
- ENTG $10.11
- P/E Ratio
- EXEL $20.36
- ENTG $42.94
- Revenue Growth
- EXEL 24.49
- ENTG N/A
- 52 Week Low
- EXEL $22.13
- ENTG $60.75
- 52 Week High
- EXEL $49.62
- ENTG $147.57
- Technical
- Relative Strength Index (RSI)
- EXEL 56.79
- ENTG 62.43
- Support Level
- EXEL $43.21
- ENTG $85.50
- Resistance Level
- EXEL $48.74
- ENTG $89.01
- Average True Range (ATR)
- EXEL 2.01
- ENTG 3.35
- MACD
- EXEL 0.05
- ENTG 0.63
- Stochastic Oscillator
- EXEL 31.61
- ENTG 90.96
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ENTG Entegris Inc.
Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.